Hyoscine Butylbromide - Risk of adverse effects in patients with underlying cardiac disease - SAHPRA

Hyoscine Butylbromide – Risk of adverse effects in patients with underlying cardiac disease

Hyoscine Butylbromide – Risk of adverse effects in patients with underlying cardiac disease

2019 Apr

Download latest version
Document Number: DHCPL
Version: 1
Date Updated: 03/04/2019
File Type: pdf
Category: Communication To Health Care Professionals
Unit: Pharmacovigilance